IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Global Longlife Hospital and Research IPO is a Fixed Price listing on BSE SME exchange. The company is based in Ahmedabad and caters to Healthcare - Hospitals And Clinic sector. Interactive Financial Services is the merchant banker of Global Longlife Hospital and Research IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 2nd March 2022.
Global Longlife Hospital and Research IPO posted revenues of ₹ 35.65 crores and PAT of ₹ 5.15 crores in FY22 on annualised basis.
Revenue:
₹ 35.35 Cr.
EBITDA Margin:
35.35
% 
Net Worth: ₹ 16.39 Cr.
Market Capitalisation:
₹ 195.78 Cr.
P/E:
38.04 times
P/BV: 2.99 times
EV/EBITDA: 16.81 times
Financial results of Global Longlife Hospital and Research IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | Dec-21 | FY21 | FY20 | FY19 | |
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 40.01 | 35.90 | 41.92 | 43.30 | |
| Net Worth | 16.39 | 12.53 | 11.49 | 12.35 | |
| Total Debt | 15.37 | 15.32 | 22.91 | 23.55 | |
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
26.51
35.35 |
32.70 | 33.54 | 34.54 | |
EBITDA
EBITDA on annualised basis |
9.37
12.49 |
6.13 | 3.47 | 6.91 | |
PAT
PAT on annualised basis |
3.86
5.15 |
1.04 | -0.86 | 1.36 | |
Global Longlife Hospital and Research IPO PAT Margin is 14.56 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Global Longlife Hospital and Research IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | Dec-21 | FY21 | FY20 | FY19 |
|---|---|---|---|---|
| EBITDA Margin (%) | 35.35 | 18.75 | 10.35 | 20.01 |
| PAT Margin (%) | 14.56 | 3.18 | -2.56 | 3.94 |
| EPS (₹) | 5.52 | 1.48 | -1.23 | 2.53 |
| ROE (%) | 23.55 | 8.30 | -7.48 | 11.01 |
| ROCE (%) | [●] | [●] | [●] | [●] |
| ROA (%) | 9.65 | 2.90 | -2.05 | 3.14 |
| Debt to Equity | 0.94 | 1.22 | 1.99 | 1.91 |
The market Capitalisation of Global Longlife Hospital and Research IPO is ₹ 195.78 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Global Longlife Hospital and Research IPO prospectus highlights an Return on Equity (ROE) of 15 %, Return on Assets (ROA) of 12 %, and an EBITDA Margin of 18 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Global Longlife Hospital and Research IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Global Longlife Hospital and Research IPO is ₹ 195.78 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Global Longlife Hospital and Research IPO has a Price-to-Earnings (PE) ratio of 38.04 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Global Longlife Hospital and Research IPO reported revenue of ₹ 35.65 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Global Longlife Hospital and Research IPO provide insights into sales growth, market demand, and business scalability.
Global Longlife Hospital and Research recorded an EBITDA of ₹ 12.49 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Global Longlife Hospital and Research Profit After Tax (PAT) is ₹ 5.15 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 35.35 Cr.
EBITDA Margin:
35.35
%
Net Worth: ₹ 16.39 Cr.
Market Capitalisation:
₹ 195.78 Cr.
P/E:
38.04 times
P/BV: 2.99 times
EV/EBITDA: 16.81 times
Global Longlife Hospital and Research operates in Healthcare - Hospitals And Clinic and Provides Healthcare Services. The Issue is listed on BSE SME in May, 2022. Global Longlife Hospital and Research IPO size was 49.00 with Issue price of 140.00 .
Merchant Banker(s) of Global Longlife Hospital and Research IPO: Interactive Financial Services Limited
Global Longlife Hospital and Research IPO subscription was 1.50 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Global Longlife Hospital and Research IPO listed at a listing price of 135.35 against the offer price of 140.00.
The current market price of Global Longlife Hospital and Research is 23.90.
Why Us?
